Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Modelling the genital herpes epidemic.

Sally Blower1

  • 1Department of Biomathematics, David Geffen School of Medicine at UCLA, Los Angeles, CA 90024, USA. sblower@mednet.ucla.edu

Herpes : the Journal of the IHMF
|August 21, 2004
PubMed
Summary

Mathematical models show antiviral therapies can reduce herpes simplex virus type 2 (HSV-2) transmission. Suppressive therapy, alongside safer sex and vaccines, offers significant potential for controlling the genital herpes epidemic.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Analysis of travel-time to HIV treatment in sub-Saharan Africa reveals inequities in access to antiretrovirals.

Communications medicine·2025
Same author

Long-acting HIV preventive treatments for remote rural communities.

Lancet (London, England)·2025
Same author

Extreme geographic misalignment of healthcare resources and HIV treatment deserts in Malawi.

Nature medicine·2025
Same author

The Future of HIV: Challenges in meeting the 2030 <i>Ending the HIV Epidemic in the U.S. (EHE)</i> reduction goal.

medRxiv : the preprint server for health sciences·2025
Same author

The future of HIV: challenges in meeting the 2030 Ending the HIV Epidemic in the US (EHE) reduction goal.

AIDS (London, England)·2025
Same author

Modeling Travel Time to HIV Treatment in Malawi: Identifying Rural-Urban and Wealth Inequities.

Journal of acquired immune deficiency syndromes (1999)·2024

Area of Science:

  • Epidemiology
  • Mathematical Modeling
  • Virology

Background:

  • Herpes simplex virus type 2 (HSV-2) poses a significant public health challenge.
  • Mathematical models are crucial for understanding and predicting epidemic trends.
  • Previous models have explored interventions for HSV-2, but impact of suppressive therapy needed further investigation.

Purpose of the Study:

  • To evaluate the impact of antiviral treatment on HSV-2 transmission using mathematical models.
  • To assess the potential for drug resistance to antiviral therapies.
  • To compare the effectiveness of episodic versus suppressive antiviral therapy.

Main Methods:

  • Utilized four distinct mathematical models to simulate HSV-2 transmission dynamics.
  • Incorporated factors such as behavioral changes, antiviral drug usage, and vaccine development.
  • One model specifically focused on virological core groups to assess suppressive therapy impact on both incident and prevalent infections.

Main Results:

  • Antiviral drug resistance to HSV-2 treatments is predicted to be minimal, with less than 5 in 10,000 individuals shedding resistant virus after 25 years.
  • Increased use of episodic antiviral therapy is beneficial for reducing the HSV-2 epidemic.
  • Preventative measures like safer sex, reduced non-monogamous relationships, and therapeutic vaccines can significantly lower transmission rates.
  • While initial models suggested minimal impact, more recent models show suppressive therapy can substantially reduce HSV-2 incidence rates when applied to both incident and prevalent infections.

Conclusions:

  • Mathematical modeling supports the use of antiviral therapies to control the HSV-2 epidemic.
  • Suppressive antiviral therapy, particularly when targeting both new and existing infections, shows significant promise in reducing HSV-2 incidence.
  • Combined strategies including behavioral changes, preventative measures, and effective vaccines are essential for comprehensive HSV-2 epidemic control.

Related Experiment Videos